Secrets of the opium poppy revealed

Neuropharmacology

Volumn 47, Issue SUPPL. 1, 2004, Pages 293-299

  Evans, Christopher J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Morphine; Opioid signaling; Receptor type

Indexed keywords

ADENYLATE CYCLASE; BETA ENDORPHIN; BUPRENORPHINE; CALMODULIN; G PROTEIN COUPLED RECEPTOR; ION CHANNEL; LEUCINE ENKEPHALIN; METHIONINE; MITOGEN ACTIVATED PROTEIN KINASE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NALOXONE; NOCICEPTIN; OPIATE; OPIATE RECEPTOR; PHOSPHOTRANSFERASE; PROOPIOMELANOCORTIN; PROTEIN SUBUNIT; PROTEINASE; RETINA S ANTIGEN;

ADDICTION; AMINO ACID SEQUENCE; BINDING AFFINITY; DRUG ABUSE; DRUG PROTEIN BINDING; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; LIPID MEMBRANE; NERVE CELL PLASTICITY; NEUROANATOMY; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 4644374022     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2004.06.016     Document Type: Article

References (33)

1. Akil H., Watson S.J., Young E., Lewis M.E., Khachaturian H., Walker J.M. Endogenous opioids: biology and function. Annu. Rev. Neurosci. 7:1984;223-255
2. Bodnar R.J., Hadjimarkou M.M. Endogenous opiates and behavior: 2002. Peptides. 24:2003;1241-1302
3. Charles A.C., Mostovskaya N., Asas K., Evans C.J., Dankovich M.L., Hales T.G. Coexpression of delta-opioid receptors with micro receptors in GH3 cells changes the functional response to micro agonists from inhibitory to excitatory. Mol. Pharmacol. 63:2003;89-95
4. Eitan S., Bryant C.D., Saliminejad N., Yang Y.C., Vojdani E., Keith D. Jr., Polakiewicz R., Evans C.J. Brain region-specific mechanisms for acute morphine-induced mitogen-activated protein kinase modulation and distinct patterns of activation during analgesic tolerance and locomotor sensitization. J. Neurosci. 23:2003;8360-8369
5. Evans C.J., Keith D.E. Jr., Morrison H., Magendzo K., Edwards R.H. Cloning of a δ opioid receptor by functional expression. Science. 258:1992;1952-1955
6. Evans C.J., Monteillet-Agius G., Saliminejad N., Zaki P.A. Opiate drugs: 'guilt by association'. Mol. Psychiatr. 5:2000;122-123
7. Gaveriaux-Ruff C., Kieffer B.L. Opioid receptor genes inactivated in mice: the highlights. Neuropeptides. 36:2002;62-71
8. Grant S.G. Synapse signalling complexes and networks: machines underlying cognition. Bioessays. 25:2003;1229-1235
9. Haberstock-Debic H., Wein M., Barrot M., Colago E.E., Rahman Z., Neve R.L., Pickel V.M., Nestler E.J., von Zastrow M., Svingos A.L. Morphine acutely regulates opioid receptor trafficking selectively in dendrites of nucleus accumbens neurons. J. Neurosci. 23:2003;4324-4332
10. Kieffer B.L. Recent advances in molecular recognition and signal transduction of active peptides - receptors for opioid peptides. Cell. Mol. Neurobiol. 15:1995;615-635
11. Kieffer B.L., Evans C.J. Opioid tolerance - in search of the holy grail. Cell. 108:2002;587-590
12. Kieffer B.L., Befort K., Gaveriaux-Ruff C., Hirth C.G. The δ opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc. Natl. Acad. Sci. USA. 89:1992;12048-12052
13. Li Y., Eitan S., Wu J., Evans C.J., Kieffer B., Sun X., Polakiewicz R.D. Morphine induces desensitization of insulin receptor signaling. Mol. Cell. Biol. 23:2003;6255-6266
14. Lutfy K., Eitan S., Bryant C.D., Yang Y.C., Saliminejad N., Walwyn W., Kieffer B.L., Takeshima H., Carroll F.I., Maidment N.T., Evans C.J. Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors. J. Neurosci. 23:2003;10331-10337
15. Mansour A., Fox C.A., Akil H., Watson S.J. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 18:1995;22-29
16. Martin W.R., Eades C.G., Thompson J.A., Huppler R.E., Gilbert P.E. The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 197:1976;517-532
17. Meilandt W.J., Barea-Rodriguez E., Harvey S.A., Martinez J.L. Jr. Role of hippocampal CA3 micro-opioid receptors in spatial learning and memory. J. Neurosci. 24:2004;2953-2962
18. Mennicken F., Zhang J., Hoffert C., Ahmad S., Beaudet A., O'Donnell D. Phylogenetic changes in the expression of delta opioid receptors in spinal cord and dorsal root ganglia. J. Comp. Neurol. 465:2003;349-360
19. Milligan G., MacEwan D.J., Mercouris M., Mullaney I. Inverse agonism at adrenergic and opioid receptors: studies with wild type and constitutively active mutant receptors. Receptors Channels. 5:1997;209-213
20. Nestler E.J. Historical review: molecular and cellular mechanisms of opiate and cocaine addiction. Trends Pharmacol. Sci. 25:2004;210-218
21. Pasternak G.W. Pharmacological mechanisms of opioid analgesics. Clin. Neuropharmacol. 16:1993;1-18
22. Peckys D., Landwehrmeyer G.B. Expression of mu, kappa, and delta opioid receptor messenger RNA in the human CNS: a 33P in situ hybridization study. Neuroscience. 88:1999;1093-1135
23. Rios C.D., Jordan B.A., Gomes I., Devi L.A. G-protein-coupled receptor dimerization: modulation of receptor function. Pharmacol. Ther. 92:2001;71-87
24. Robinson T.E., Gorny G., Savage V.R., Kolb B. Widespread but regionally specific effects of experimenter- versus self-administered morphine on dendritic spines in the nucleus accumbens, hippocampus, and neocortex of adult rats. Synapse. 46:2002;271-279
25. Rubino T., Forlani G., Vigano D., Zippel R., Parolaro D. Modulation of extracellular signal-regulated kinases cascade by chronic Delta(9)- tetrahydrocannabinol treatment. Mol. Cell. Neurosci. 25:2004;355-362
26. Thomas G.M., Huganir R.L. MAPK cascade signalling and synaptic plasticity. Nat. Rev. Neurosci. 5:2004;173-183
27. von Zastrow M., Svingos A., Haberstock-Debic H., Evans C. Regulated endocytosis of opioid receptors: cellular mechanisms and proposed roles in physiological adaptation to opiate drugs. Curr. Opin. Neurobiol. 13:2003;348-353
28. Wang D., Sadee W., Quillan J.M. Calmodulin binding to G protein-coupling domain of opioid receptors. J. Biol. Chem. 274:1999;22081-22088
29. Weber E., Evans C.J., Barchas J.D. Multiple endogenous ligands for opioid receptors. Trends Neurosci. 6:1983;333-336
30. Wei L.N., Law P.Y., Loh H.H. Post-transcriptional regulation of opioid receptors in the nervous system. Front. Biosci. 9:2004;1665-1679
31. Whistler J.L., von Zastrow M. Morphine-activated opioid receptors elude desensitization by beta-arrestin. Proc. Natl. Acad. Sci. USA. 95:1998;9914-9919
32. Zaki P.A., Evans C.J. ORL-1: an awkward child of the opioid receptor family. Neuroscientist. 4:1998;172-184
33. Zaki P.A., Bilsky E.J., Vanderah T.W., Lai J., Evans C.J., Porreca F. Opioid receptor types and subtypes: the δ receptor as a model. Annu. Rev. Pharmacol. Toxicol. 36:1996;379-401